The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia
Abstract
A propensity for rewiring genetic and epigenetic regulatory networks, thus enabling sustained cell proliferation, suppression of apoptosis, and the ability to evade the immune system, is vital to cancer cell propagation. An increased understanding of how this is achieved is critical for identifying or improving therapeutic interventions. In this study, using acute myeloid leukemia (AML) human cell lines and a custom CRISPR/Cas9 screening platform, we identify the H3K9 methyltransferase SETDB1 as a novel, negative regulator of innate immunity. SETDB1 is overexpressed in many cancers, and loss of this gene in AML cells triggers desilencing of retrotransposable elements that leads to the production of double-stranded RNAs (dsRNAs). This is coincident with induction of a type I interferon response and apoptosis through the dsRNA-sensing pathway. Collectively, our findings establish a unique gene regulatory axis that cancer cells can exploit to circumvent the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Loss of SETDB1 leads to the induction of viral response genes. (A) Volcano plot of RNA-seq gene expression changes in THP-1–Cas9 cells after 4 d of treatment with representative SETDB1-specific sgRNA relative to NTC (DESeq2 log2 fold changes vs. significance −log10 [q-value], and n = 3 biological replicates). ISGs are highlighted in blue. (B) Bar plot of top 30 induced genes (ISGs are in blue) in THP-1–Cas9 cells after treatment with two SETDB1-specific sgRNAs (6 and 9) at day 4. Mean fold change was calculated using the fold changes for each SETDB1-specific sgRNA relative to NTC, and n = 3 biological replicates. (C) Panther gene ontology analysis shows most significantly enriched biological processes after SETDB1 disruption at day 4 (genes up-regulated/down-regulated ≥1.5-fold in both cells treated with SETDB1 sgRNAs 6 and 9 were used for the analysis). (D) Taqman qRT-PCR validation of RNA-seq data on day 4, showing relative expression of IFN-inducible transcripts after treatment with SETDB1 sgRNAs or an NTC control sgRNA. n = 3 experiments, and Student’s t tests were performed. (E) Taqman qRT-PCR data on day 4 showing relative expression of IFN-β and ERV3-1 as well as ISGs at day 7 after treatment of three different SETDB1 disruption-sensitive AML lines with SETDB1-specific or NTC sgRNAs. n = 3 experiment, and Student’s t tests were performed. Error bars represent standard deviation. (D and E) ns, not significant, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P ≤ 0.0001.](/paper-figures/d7302ce2111a4b87a7e2e0efbca5f347/silencing-of-retrotransposons-by-setdb1-inhibits-the-interferon-response-in-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As we have previously identified retrotransposons that are elevated in postmortem human Alzheimer’s disease brain (6) and retrotransposons are known to form dsRNA in other human disorders (8), we first determined whether the presence of dsRNA correlates with the degree of pathogenic tau burden in the human brain.”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [8]
In the citing paper
“While retrotransposons are known to drive inflammation in other human disorders (1, 8–11) and studies in the tauopathy field clearly suggest that pathogenic forms of tau activate retrotransposons across model systems, it is currently unknown whether tau-induced retrotransposon activation contributes to neuroinflammation.”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [8]
In the citing paper
“An accumulating set of data suggest that retrotransposon activation is consistently immunogenic in a variety of human disorders, a process initiated by the detection of retrotransposon-derived nucleic acids via dsRNA-sensing machinery RIG-I/MDA5, PKR, and adenosine deaminase acting on RNA (ADAR) (1, 8–11, 60).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [8]
In the citing paper
“In addition, retrotransposons and other repetitive elements are known to form immunogenic dsRNA in various human disorders (8, 40, 41).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [8]
In the citing paper
“In models of amyotrophic lateral sclerosis (ALS) and cancers such as acute myeloid leukemia, decondensation of LINE elements triggers RIG-I–mediated immune responses (8, 11, 61).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs017 · Cited by 9,049
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Research works printed but not linked: 58
- Aguirre, 2016, Genomic copy number dictates a gene-independent cell Response to CRISPR/Cas9 targeting, Cancer Discov., 6, 914, 10.1158/2159-8290.CD-16-0154 · DOI · Paper page
- Brind’Amour, 2015, An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations, Nat. Commun., 6, 6033, 10.1038/ncomms7033 · DOI · Paper page
- Cherkasova, 2013, Corticosteroid hormones and angiotensin-converting enzyme in the dynamics of chronic granulomatous inflammation, Patol. Fiziol. Eksp. Ter., 2, 26
- Collins, 2015, The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes, Proc. Natl. Acad. Sci. USA., 112, 8367, 10.1073/pnas.1422187112 · DOI
- Criscione, 2014, Transcriptional landscape of repetitive elements in normal and cancer human cells, BMC Genomics., 15, 583, 10.1186/1471-2164-15-583 · DOI · Paper page
- Cruickshanks, 2013, Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer, Nucleic Acids Res., 41, 6857, 10.1093/nar/gkt438 · DOI
- Daigle, 2011, Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor, Cancer Cell., 20, 53, 10.1016/j.ccr.2011.06.009 · DOI · Paper page
- Domansky, 2000, Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region, FEBS Lett., 472, 191, 10.1016/S0014-5793(00)01460-5 · DOI
- Dunn, 2006, Transcription of two human genes from a bidirectional endogenous retrovirus promoter, Gene., 366, 335, 10.1016/j.gene.2005.09.003 · DOI
- Ehrlich, 2002, DNA methylation in cancer: too much, but also too little, Oncogene., 21, 5400, 10.1038/sj.onc.1205651 · DOI · Paper page
- Ehrlich, 2009, DNA hypomethylation in cancer cells, Epigenomics., 1, 239, 10.2217/epi.09.33 · DOI · Paper page
- Erwin, 2016, L1-associated genomic regions are deleted in somatic cells of the healthy human brain, Nat. Neurosci., 19, 1583, 10.1038/nn.4388 · DOI · Paper page
- Faulkner, 2009, The regulated retrotransposon transcriptome of mammalian cells, Nat. Genet., 41, 563, 10.1038/ng.368 · DOI · Paper page
- Fei, 2015, Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53, Nat. Commun., 6, 8651, 10.1038/ncomms9651 · DOI · Paper page
- Fellmann, 2013, An optimized microRNA backbone for effective single-copy RNAi, Cell Reports., 5, 1704, 10.1016/j.celrep.2013.11.020 · DOI · Paper page
- Hanahan, 2011, Hallmarks of cancer: the next generation, Cell., 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Hart, 2015, High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities, Cell., 163, 1515, 10.1016/j.cell.2015.11.015 · DOI · Paper page
- Haubold, 2006, How repetitive are genomes?, BMC Bioinformatics., 7, 541, 10.1186/1471-2105-7-541 · DOI
- Howard, 2008, Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice, Oncogene., 27, 404, 10.1038/sj.onc.1210631 · DOI · Paper page
- Hubley, 2016, The Dfam database of repetitive DNA families, Nucleic Acids Res., 44, D81, 10.1093/nar/gkv1272 · DOI · Paper page
- Jinek, 2013, RNA-programmed genome editing in human cells, eLife., 2, e00471, 10.7554/eLife.00471 · DOI · Paper page
- Kanellopoulou, 2005, Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing, Genes Dev., 19, 489, 10.1101/gad.1248505 · DOI · Paper page
- Karmodiya, 2012, H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells, BMC Genomics., 13, 424, 10.1186/1471-2164-13-424 · DOI · Paper page
- Kassiotis, 2016, Immune responses to endogenous retroelements: taking the bad with the good, Nat. Rev. Immunol., 16, 207, 10.1038/nri.2016.27 · DOI · Paper page
- Koide, 2016, Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes, Blood., 128, 638, 10.1182/blood-2016-01-694810 · DOI
- Lander, 2001, Initial sequencing and analysis of the human genome, Nature., 409, 860, 10.1038/35057062 · DOI · Paper page
- Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol., 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
- Li, H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. arXiv:1303.3997 (Preprint posted March 16, 2013) · arXiv
- Liu, 2015, Genetic alterations of histone lysine methyltransferases and their significance in breast cancer, Oncotarget., 6, 2466, 10.18632/oncotarget.2967 · DOI · Paper page
- Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 · DOI · Paper page
- Maile, 2015, Mass spectrometric quantification of histone post-translational modifications by a hybrid chemical labeling method, Mol. Cell. Proteomics., 14, 1148, 10.1074/mcp.O114.046573 · DOI
- Maksakova, 2011, H3K9me3-binding proteins are dispensable for SETDB1/H3K9me3-dependent retroviral silencing, Epigenetics Chromatin., 4, 12, 10.1186/1756-8935-4-12 · DOI
- Matsui, 2010, Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET, Nature., 464, 927, 10.1038/nature08858 · DOI · Paper page
- Mi, 2017, PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements, Nucleic Acids Res., 45, D183, 10.1093/nar/gkw1138 · DOI · Paper page
- Munoz, 2016, CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions, Cancer Discov., 6, 900, 10.1158/2159-8290.CD-16-0178 · DOI · Paper page
- Mwenifumbo, 2013, Cancer genome-sequencing study design, Nat. Rev. Genet., 14, 321, 10.1038/nrg3445 · DOI
- Pépin, 2016, Cre-dependent DNA recombination activates a STING-dependent innate immune response, Nucleic Acids Res., 44, 5356, 10.1093/nar/gkw405 · DOI
- Plass, 2008, Epigenetics in acute myeloid leukemia, Semin. Oncol., 35, 378, 10.1053/j.seminoncol.2008.04.008 · DOI
- Robinson, 2011, Integrative genomics viewer, Nat. Biotechnol., 29, 24, 10.1038/nbt.1754 · DOI · Paper page
- Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics., 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- Rodić, 2015, Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma, Nat. Med., 21, 1060, 10.1038/nm.3919 · DOI
- Rodriguez-Paredes, 2014, Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis, Oncogene., 33, 2807, 10.1038/onc.2013.239 · DOI
- Roulois, 2015, DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts, Cell., 162, 961, 10.1016/j.cell.2015.07.056 · DOI · Paper page
- Rowe, 2013, De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET, Development., 140, 519, 10.1242/dev.087585 · DOI · Paper page
- Sasca, 2016, Independence of epigenetic and genetic diversity in AML, Nat. Med., 22, 708, 10.1038/nm.4136 · DOI
- Shi, 2015, Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains, Nat. Biotechnol., 33, 661, 10.1038/nbt.3235 · DOI · Paper page
- Shih, 2012, The role of mutations in epigenetic regulators in myeloid malignancies, Nat. Rev. Cancer., 12, 599, 10.1038/nrc3343 · DOI · Paper page
- Sun, 2015, SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway, J. Pathol., 235, 559, 10.1002/path.4482 · DOI
- Sun, 2014, Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion, Asian J. Androl., 16, 319, 10.4103/1008-682X.122812 · DOI
- Tchasovnikarova, 2015, Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells, Science., 348, 1481, 10.1126/science.aaa7227 · DOI · Paper page
- Tsuchiya, 1980, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int. J. Cancer., 26, 171, 10.1002/ijc.2910260208 · DOI · Paper page
- Tzelepis, 2016, A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia, Cell Reports., 17, 1193, 10.1016/j.celrep.2016.09.079 · DOI · Paper page
- Vinogradova, 2016, An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells, Nat. Chem. Biol., 12, 531, 10.1038/nchembio.2085 · DOI · Paper page
- Weber, 2006, Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses, J. Virol., 80, 5059, 10.1128/JVI.80.10.5059-5064.2006 · DOI · Paper page
- Wu, 2016, GMAP and GSNAP for genomic sequence alignment: Enhancements to speed, accuracy, and functionality, Methods Mol. Biol., 1418, 283, 10.1007/978-1-4939-3578-9_15 · DOI · Paper page
- Yang, 2006, L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells, Nat. Struct. Mol. Biol., 13, 763, 10.1038/nsmb1141 · DOI · Paper page
- Zeller, 2016, Histone H3K9 methylation is dispensable for Caenorhabditis elegans development but suppresses RNA:DNA hybrid-associated repeat instability, Nat. Genet., 48, 1385, 10.1038/ng.3672 · DOI · Paper page
- Zhang, 2008, Model-based analysis of ChIP-Seq (MACS), Genome Biol., 9, R137, 10.1186/gb-2008-9-9-r137 · DOI · Paper page
Cited by
Targeting the epigenetic regulation of antitumour immunity
Hogg, S. J., Beavis, P. A., Dawson, M. A., & Johnstone, R. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0077-5 · Cited by 630
Epigenetic therapy in immune-oncology
Jones, P. A., Ohtani, H., Chakravarthy, A., & De Carvalho, D. D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0109-9 · Cited by 550
Heterochromatin: Guardian of the Genome
Janssen, A., Colmenares, S. U., & Karpen, G. H. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062653 · Cited by 500
Regulation of transposable elements by DNA modifications
Deniz, Ö., Frost, J. M., & Branco, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0106-6 · Cited by 486
Cellular origins of dsRNA, their recognition and consequences
Chen, Y. G., & Hur, S. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00430-1 · Cited by 433
Metadata
- Authors
- Cuellar, T. L., Herzner, A.-M., Zhang, X., Goyal, Y., Watanabe, C., Friedman, B. A., Janakiraman, V., Durinck, S., Stinson, J., Arnott, D., Cheung, T. K., Chaudhuri, S., Modrusan, Z., Doerr, J. M., Classon, M., & Haley, B.
- Affiliations
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 1
- Department of Human Genetics, Genentech, Inc., South San Francisco, CA 2
- Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA 3
- Department of Protein Chemistry, Genentech, Inc., South San Francisco, CA 4
- Department of Discovery Oncology, Genentech, Inc., South San Francisco, CA 5
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2017-09-08
- Volume
- 216
- Issue
- 11
- Pages
- 3535-3549
- ISSN
- 0021-9525
- 1540-8140
- PMC
- PMC5674883
- Cited by
- 227
- References
- 22
- Language
- en
- Funders
- Genentech, Inc.
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia. https://app.cochat.ai/papers/10.1083/jcb.201612160
- The paper
- Cuellar, T. L., Herzner, A.-M., Zhang, X., Goyal, Y., Watanabe, C., Friedman, B. A., Janakiraman, V., Durinck, S., Stinson, J., Arnott, D., Cheung, T. K., Chaudhuri, S., Modrusan, Z., Doerr, J. M., Classon, M., & Haley, B. (2017). Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia. Journal of Cell Biology. https://doi.org/10.1083/jcb.201612160
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.